NCT00846625View on ClinicalTrials.gov

Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2009

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Macular EdemaUveitis
Interventions
DRUG

triamcinolone

Intravitreal injection (4 mg/0.1 ml)

DRUG

ranibizumab

Intravitreal injection, 0.5 mg

Trial Locations (1)

84132

John Moran Eye Center, Salt Lake City

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

University of Utah

OTHER

NCT00846625 - Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids | Biotech Hunter | Biotech Hunter